Enanta Pharmaceuticals Inc (ENTA) — Capital Reinvestment Ratio
Latest as of June 2025:
0.01x
Enanta Pharmaceuticals Inc (ENTA) has a Capital Reinvestment Ratio of 0.01x as of June 2025, meaning it reinvests 0% of its operating cash flow ($17.51 Million) in capital expenditures ($155.00K). See Enanta Pharmaceuticals Inc (ENTA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$17.51 Million
USD
Capital Expenditures
$155.00K
USD
Data as of
Jun 2025
Most recent filing
Enanta Pharmaceuticals Inc Capital Reinvestment Ratio (2011–2020)
This chart tracks Enanta Pharmaceuticals Inc's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Enanta Pharmaceuticals Inc (2011–2020)
Year-by-year Capital Reinvestment Ratio for Enanta Pharmaceuticals Inc from 2011 to 2020. For live market cap and broader valuation context, see how much is Enanta Pharmaceuticals Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.20x | $7.09 Million | $1.45 Million | ▲ +168.8% |
| 2019 | 0.08x | $71.42 Million | $5.42 Million | ▼ -25.7% |
| 2018 | 0.10x | $29.22 Million | $2.98 Million | ▲ +114.4% |
| 2017 | 0.05x | $52.65 Million | $2.51 Million | ▼ -64.0% |
| 2016 | 0.13x | $35.81 Million | $4.74 Million | ▲ +334.3% |
| 2015 | 0.03x | $76.67 Million | $2.34 Million | ▼ -40.2% |
| 2014 | 0.05x | $20.18 Million | $1.03 Million | ▼ -10.4% |
| 2013 | 0.06x | $10.65 Million | $606.00K | ▲ +410.7% |
| 2012 | 0.01x | $22.62 Million | $252.00K | ▼ -39.9% |
| 2011 | 0.02x | $24.02 Million | $445.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow